101
Participants
Start Date
March 31, 2011
Primary Completion Date
November 30, 2015
Study Completion Date
June 30, 2018
temsirolimus
175mg IV once a week for first 3 weeks, followed by 75mg IV once a week until disease progression, provided that patient is tolerating treatment and getting clinical benefit
temsirolimus
75mg IV once a week until until disease progression, provided that patient is tolerating treatment and getting clinical benefit
St George Hospital, Kogarah
The Alfred Hospital, Melbourne
Box Hill Hospital, Box Hill
Royal Adelaide Hospital, Adelaide
Royal Hobart Hospital, Hobart
Fakultni nemocnice Kralovske Vinohrady, Prague
Struttura Complessa di Ematologia, Dipartimento di Oncologia ed Ematologia-, Torino
Clinical Centre of Serbia,Clinic for Hematology, Belgrade
Oncology Institute of Vojvodina, Kamenitz
Mercy Research Institute, Miami
Dipartimento di Medicina Diagnostica, Clinica e di Sanità Pubblica, Modena
Klinik fuer Onkologie und Haematologie, Medizinische Klinik IV, Aachen
CHU de Nancy, Vandœuvre-lès-Nancy
Klinikum Johannes-Gutenberg -Universitaet, III. Medizinische Klinik und Poliklinik, Mainz
Mercy Clinic Oklahoma Communities dba Mercy Clinic Oncology/Hematology-McAuley, Oklahoma City
Mercy Hospital Oklahoma City-Oncology Infusion, Oklahoma City
Presidio Ferrarotto - A.O.U. - PoliclinicoVittorio Emanuele, Catania
Amy Shen, RPh, Seattle
VA Puget Sound Health Care System, Seattle
"GBOU VPO First Saint-Petersburg State Medical University n.a. I.P.Pavlov", Saint Petersburg
Institute of Pediatric Hematology and Transplantology R.M.Gorbacheva, Saint Petersburg
Republican Clinical Oncology Dispensary of the Ministry of Healthcare of Tatarstan Republic, Kazan'
Veterans Affairs New Jersey Healthcare System-Hematology/Oncology Section (111), East Orange
Fakultni nemocnice Kralovske Vinohrady, Prague
Vseobecna fakultni nemocnice v Praze, Prague
Malopolskie Centrum Medyczne S.C., Krakow
Institutul Clinic Fundeni Bucuresti, Sectia II Hematologie, Bucharest
Spitalul Clinic Coltea, Clinica de Hematologie, Bucharest
Spitalul Universitar de Urgenta Bucuresti, Clinica de Hematologie, Bucharest
Severance Hospital, Yonsei University, Seoul
Samsung Medical Center, Seoul
Lead Sponsor
Pfizer
INDUSTRY